Results 13,301-13,320 of 26,685 for speaker:David Cullinane

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: That helps us as members of the committee and is a reasonable response. Why is that not in this report? When the Comptroller and Auditor General completes his report, does it go to the HSE for comment?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: I do not see that response in this.

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: However, the footnote does not explain it. It just states that the Eastern Regional Health Authority was subsumed. There is a clear observation that a report was done but never published and there was no implementation plan. There were going to be obvious questions as to why it was not done.

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: My quarrel is not with Mr. Breslin or even with the Comptroller and Auditor General. I am just saying it would have been more helpful if that had been incorporated into the report. We would have been in a better position to understand that.

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: I have another question. I am nearly finished. The Comptroller and Auditor General makes a number of observations on the national hepatitis C strategy from 2011 to 2014. The first is that there were 34-----

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: There were 36 recommendations and some of them have not been implemented. Mr. McCarthy says that the strategy did not set target outputs in terms of overall treatment numbers. I always look to targets being set to ensure we have a sense of what the output will be and we can measure progress. Is that his observation?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: Was that considered then?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: Did Mr. McCarthy see that as a weakness in the strategy?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: Could that be addressed? First, why was that quantifiable target not made? Second, how many of the 36 recommendations have been implemented? Did Mr. McCarthy deal with that? How many were not implemented?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: Okay.

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: The questions were not answered. One was about why there were no targets and the second was about why the recommendations have not been fully implemented.

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: Can the witness deal with the absence of setting target outputs as well?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: I will hold Professor McCormick there because this is important in terms of the work Mr. McCarthy does for us. That appears to be a reasonable response. I assume it was communicated to the Comptroller and Auditor General but it is still stated in the report that there was a weakness. Was it not accepted?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: The point is that it is creating demand.

Microgeneration Support Scheme Bill 2017: Second Stage [Private Members] (27 Nov 2018)

David Cullinane: I commend my colleague, Deputy Stanley, on proposing this Bill which I hope the Government will support. It is about making the transition from fossil fuel to renewable energy which must take place as a matter of urgency. The legislation proposes to allow small-scale household production of electricity through solar or wind energy. It provides that excess electricity produced by...

Written Answers — Department of Health: Hospital Staff Data (27 Nov 2018)

David Cullinane: 381. To ask the Minister for Health if the use of the vascular laboratory at University Hospital Waterford is curtailed due to a lack of staff; if so, the staff shortages that exist; the number of consultants and junior doctors assigned to vascular services in each of the years 2015 to 2017 and to date in 2018 at UHW; the efforts being made to address the problem; and if he will make a...

Written Answers — Department of Health: Patient Data (27 Nov 2018)

David Cullinane: 382. To ask the Minister for Health if patients to the ENT ward at University Hospital Waterford who had an ear test in recent years have been recalled for a second ear test; if so, the reason for retesting; the number of persons retested; if more retesting is scheduled; and if so, the number that require a retest; and if he will make a statement on the matter. [49018/18]

Written Answers — Department of Health: Pharmaceutical Sector (27 Nov 2018)

David Cullinane: 419. To ask the Minister for Health if his attention has been drawn to the case of a person (details supplied); and if he will make a statement on the matter. [49251/18]

Irish Human Rights and Equality Commission (Gender Pay Gap Information) Bill 2017: Second Stage [Private Members] (28 Nov 2018)

David Cullinane: I commend the Labour Party on introducing this Bill. I do not accept the reasons the Minister of State gave for not accepting it. I heard Deputy Lisa Chambers outline the reasons the Government should support the Bill. There are various stages in legislation that enable us to perfect Bills. We have introduced many Bills to improve workers' rights and Fianna Fáil did not support them...

Written Answers — Department of Foreign Affairs and Trade: General Government Debt (29 Nov 2018)

David Cullinane: 77. To ask the Minister for Finance if he will provide Ireland’s national debt as a percentage of Government total revenue in each of the years 1997 to 2017, in tabular form; and if he will make a statement on the matter. [49976/18]